Clinical Research Berlin expands scope of study

11.07.2022 12:08

Clariness, a global digital patient recruitment company, has expanded its contract with Klinische Forschungs Berlin GbR (Klifo Berlin GbR) by adding additional studies to its ClinLife platform. It is the third contract extension between the companies. To date, more than 75 patients have been included and randomized in studies for KFB via Clariness' global patient portal, ClinLife.

Klifo Berlin GbR, a professional study center, has listed several studies on Clariness' patient-friendly ClinLife study platform since March 2021.

“Clariness supported us in patient recruitment in nine studies with six different indications, which enabled us to accelerate recruitment and increase screening and randomization numbers,” says Isabelle Schenkenberger, Principal Investigator at Klinische Forschungs Berlin GbR. “Submission of study prospects has been consistent and consistent, so we look forward to the results of continued patient recruitment through ClinLife Registry.”

Moritz Kloss, Vice President of ClinLife Registry, comments: “Our digital target group approach and our multi-channel reach have expanded the patient reach of Klifo Berlin GbR and also resulted in a significant number of submissions from prospective studies and randomizations. We are proud to be able to continue to support Klifo Berlin GbR’s patient recruitment for various diseases such as asthma, COPD, and irritable bowel syndrome (IBD).”

Clariness' ClinLife platform says it is already available in more than 50 countries and 35 different languages and recruits according to studies and indications to reduce traditional recruitment times. Healthy volunteers and patients who either suffer from a currently untreatable disease or are dissatisfied with current treatments can learn about available studies and register on a patient-centered platform.